Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
170 participants
INTERVENTIONAL
2013-09-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV
NCT01900236
PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders
NCT02438592
Re-engagement at Discharge 2
NCT05694546
Implementation a Data-to-Care Strategy to Improve HIV Continuum Outcomes for Out of Care People Living With HIV (PLWH) in Ukraine
NCT05821413
HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission
NCT02044484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Patients randomized to the intervention arm receive intensive social work case management based on the ARTAS (Antiretroviral Treatment and Access to Services) model. Patients may participate in 6-12 visits over a six-month period aimed at addressing barriers to re-engagement in HIV care. Participants complete a battery of research questions at Baseline, 6-months, and 12-months and HIV-1 viral load and CD4 count labwork at Baseline and at 12-months post enrollment.
Modified ARTAS (Antiretroviral Treatment and Access to Services) intervention
Usual Care
Patients randomized to the usual care arm are provide contact information for an HIV primary care clinic and for local AIDS service organizations. Patients are then encouraged to contact these organizations to re-establish care. Participants complete a battery of research questions at Baseline, 6-months, and 12-months and HIV-1 viral load and CD4 count labwork at Baseline and at 12-months post enrollment. Patients in the usual care arm are offered the intensive casework intervention after their 12-month followup is complete.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modified ARTAS (Antiretroviral Treatment and Access to Services) intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 19 years or older
* Be able and willing to provide informed consent
* Be willing to provide locator information
* Be willing to sign a HIPAA authorization form/medical record release form to facilitate medical record abstraction
* Report living in the vicinity
* Be able to communicate in English.
* Have significant cognitive or developmental impairment to the extent that they are unable to provide informed consent
* Incarcerated at the time of potential enrollment
* Are terminated via site PI decision
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Birmingham AIDS Outreach
UNKNOWN
Johns Hopkins University
OTHER
AIDS United
UNKNOWN
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James L Raper, PhD, CRNP, JD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham, 1917 HIV Clinic
Michael J Mugavero, MD, MHSc
Role: STUDY_DIRECTOR
University of Alabama at Birmingham
David S Batey, PhD, MSW, LCSW
Role: STUDY_DIRECTOR
University of Alabama at Birmingham
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F130522004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.